Detalles de la búsqueda
1.
Safety and efficacy of renal artery stenting following suboptimal renal angioplasty for de novo and restenotic ostial lesions: results from a nonrandomized, prospective multicenter registry.
J Vasc Interv Radiol
; 21(5): 627-37, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20304680
2.
24-carat gold, 14-carat gold, or platinum standards in the treatment of critical limb ischemia: bypass surgery or endovascular intervention?
J Endovasc Ther
; 16 Suppl 1: I134-46, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19317578
3.
Creative limb-salvage surgical and endovascular revascularization strategies in treating critical limb ischemia.
Surg Technol Int
; 17: 97-104, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18802888
4.
ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on performance measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease).
Circulation
; 122(24): 2583-618, 2010 Dec 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-21126978
5.
ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease). Developed in collaboration with the American Association of Cardiovascular and Pulmonary Rehabilitation; the American Diabetes Association; the Society for Atherosclerosis Imaging and Prevention; the Society for Cardiovascular Magnetic Resonance; the Society of Cardiovascular Computed Tomography; and the PAD Coalition. Endorsed by the American Academy of Podiatric Practice Management.
J Vasc Surg
; 52(6): 1616-52, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21146750
6.
ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease).
Vasc Med
; 15(6): 481-512, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21183653
7.
Predictors of in-hospital and 30-day complications of peripheral vascular interventions using bivalirudin as the primary anticoagulant: results from the APPROVE Registry.
J Invasive Cardiol
; 17(7): 356-9, 2005 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-16003019
8.
A safety and feasibility report of combined direct thrombin and GP IIb/IIIa inhibition with bivalirudin and tirofiban in peripheral vascular disease intervention: treating critical limb ischemia like acute coronary syndrome.
J Invasive Cardiol
; 17(8): 427-32, 2005 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16079449
9.
Patients with peripheral artery disease undergoing percutaneous peripheral interventions are at increased risk for complications without adequate anticoagulation.
J Invasive Cardiol
; 16 Suppl G: 18-20, 2004 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23570204
10.
The Angiomax Peripheral Procedure Registry of Vascular Events Trial (APPROVE): in-hospital and 30-day results.
J Invasive Cardiol
; 16(11): 651-6, 2004 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-15550739
11.
Bivalirudin as a foundation anticoagulant in peripheral vascular disease: a safe and feasible alternative for renal and iliac interventions.
J Invasive Cardiol
; 15(6): 334-42, 2003 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-12777673
12.
Carotid body tumor.
Int J Cardiol
; 143(1): e7-e10, 2010 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-19155078
13.
Clinical insights into the use of embolic protection devices during lower extremity peripheral vascular interventions.
J Invasive Cardiol
; 21(8): 418-22, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19652258
14.
Safety and performance of targeted renal therapy: the Be-RITe! Registry.
J Endovasc Ther
; 16(1): 1-12, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19281283
15.
Role of negative pressure wound therapy in treating peripheral vascular graft infections.
Vascular
; 16(4): 194-200, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18845099
16.
A review of the early experience with Targeted Renal Therapy for renal function preservation during endovascular and surgical treatments for cardiovascular disease.
EuroIntervention
; 3(1): 121-7, 2007 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19737695
17.
Targeted renal therapy and contrast-induced nephropathy during endovascular abdominal aortic aneurysm repair: results of a feasibility pilot trial.
J Endovasc Ther
; 14(4): 520-7, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17696627
18.
Safety and efficacy of staple-mediated femoral arteriotomy closure: results from a randomized multicenter study.
Catheter Cardiovasc Interv
; 67(4): 546-53, 2006 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-16538688
19.
Midterm outcomes from the TALON Registry: treating peripherals with SilverHawk: outcomes collection.
J Endovasc Ther
; 13(5): 592-602, 2006 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17042658
20.
Procedural and clinical outcomes with catheter-based plaque excision in critical limb ischemia.
J Endovasc Ther
; 13(1): 12-22, 2006 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-16445317